ArticleScientific reports2025
A J-shaped relationship between hemoglobin levels and chronic kidney disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High-Altitude Residence, Blood Biomarkers, and Chronic Disease Risk in Middle-Aged and Older Chinese Adults.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
To evaluate the connection between hemoglobin and chronic kidney disease in the adult population at high altitudes. 380 people who were at least 18 years old were invited to participate in this cross-sectional study, and they underwent interviews and examination for albuminuria, hematuria, estimated glomerular filtration rate (eGFR), hemoglobin, and several other essential variables from April 2021 to May 2021. The total prevalence of chronic kidney disease was 15%. During logistic regression analysis, we found that participants with elevated hemoglobin per 10 g/L had a 27% greater risk of chronic kidney disease (adjusted odds ratio (OR), 1.27; 95% confidence interval (CI), 1.09-1.48), and high-altitude polycythemia significantly increased the chronic kidney disease risk compared to the group without high-altitude polycythemia (OR, 2.44; 95% CI, 1.20-4.97, p = 0.019). Our observations further revealed a distinct J-shaped correlation between hemoglobin levels and chronic kidney disease, which had a threshold of approximately 213 g/L. The effect sizes and confidence intervals were 0.999 (0.979-1.018) below the threshold and 1.089 (1.029-1.154) above the threshold. Hemoglobin levels were significantly associated with chronic kidney disease in Tibetans. When the hemoglobin levels exceeded a certain value (approximately213 g/L), the risk of chronic kidney disease was significantly increased. High-altitude polycythemia was a risk factor for chronic kidney disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.